Abstract
Rationale: Correction of metabolic disorders is one of the important point’s supportive care during high-dose chemotherapy with autologous stem cell transplantation (autoHSCT) in patients with Hodgkin's lymphoma (HL).[1] The impact of nutritional support on recovery during autoHSCT for this group of patients is not clearly understood. We performed this trial to assess the effect of combined nutritional support on the intensity of body weight loss, sarcopenia developing, the duration of neutropenic fever (NL), the frequency of blood transfusions during high-dose chemotherapy with autoHSCT in patients with HL.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
